Centre for Sight Revenue, Valuation, Funding & Investors

Centre for Sight is valued at $192M as of May 2024, a 3.1x revenue multiple. Centre for Sight revenue was $62M and Centre for Sight EBITDA was $13M, as disclosed with its latest round.

Last Centre for Sight valuation

$192M

Undisclosed stage · May 2024

Last Centre for Sight funding round

$100M

Undisclosed stage · May 2024

Centre for Sight revenue

$62M

Undisclosed stage · May 2024

Key investors in Centre for Sight

  • Z47
  • ChrysCapital
  • Mahindra Partners
  • Mahipal Sachdev

Centre for Sight Overview


Founded

1996

HQ

IndiaIndia

Status

Privately held

Customer focus

B2C

Revenue model

Services

Revenue

$62M (May 2024)

Valuation

$192M (May 2024)

Centre for Sight Valuation

Centre for Sight is currently valued at $192M, based on its undisclosed-stage round in May 2024. Read the announcement ↗

The $100M round included ChrysCapital.

Centre for Sight valuation by funding round

Centre for Sight valuation by funding round
DateStageValuationRevenue Multiple
May 2024Undisclosed stage$192M3.1x

Centre for Sight Revenue

Centre for Sight's latest recorded revenue is $62M, as of its undisclosed-stage round in May 2024. At a $192M valuation, that implies a 3.1x revenue multiple.

Centre for Sight revenue by funding round

Centre for Sight revenue and valuation multiple by funding round
DateRevenue *ValuationRevenue MultipleStage
May 2024$62M$192M3.1xUndisclosed stage

* Revenue (or ARR) figures are the values recorded alongside each funding round. Typically run-rate revenue at the time of the deal, or a reported LTM (last 12 months) revenue.

Centre for Sight Funding History

Centre for Sight has raised a total of $137M across 3 funding rounds.

Centre for Sight's first fundraising round was a $5M Series A in July 2013. The most recent completed round was a $100M undisclosed-stage round in May 2024.

Centre for Sight funding rounds

Centre for Sight funding rounds
DateStageInvestorsRaisedValuationDeal Summary
May 2024Undisclosed stageChrysCapital$100M$192MChrysCapital announced in May 2024 that it would invest up to USD 100 million in Centre for Sight, the New Delhi eye care chain, for a significant minority stake. The investment combines fresh primary capital for the company with the purchase of the entire holding of Mahindra Holdings, a subsidiary of Mahindra and Mahindra that had invested in the chain in 2019. The funds are to support expansion, including new greenfield centres and tuck-in acquisitions. ChrysCapital managing director Raghav Ramdev said healthcare is a key focus area for the firm given the underserved market, and described the chain as having shown robust growth. Founder Mahipal Sachdev welcomed ChrysCapital as a partner. Centre for Sight was founded in 1996 and is among the three largest organised eye care chains in India. As of March 2024 it ran 83 centres across 15 states and union territories and 39 cities, with annual patient footfall above 1.5 million.
May 2019Undisclosed stageMahindra Partners (lead); Mahipal Sachdev$32M-Centre for Sight is an India-based ophthalmology chain founded in 1996 by Dr. Mahipal Sachdev, operating eye care centers across multiple cities that diagnose and treat eye disorders. On May 15, 2019, Mahindra Partners invested INR 206.5 crore in a mix of primary and secondary transactions, with promoters adding INR 20 crore, totaling INR 226.5 crore; this enabled early investor Matrix Partners India to fully exit its stake from a prior 2013 investment. The funds were intended to support organic growth by opening new centers, inorganic expansion through acquisitions, and consolidating leadership in the Indian ophthalmology healthcare segment. Mahindra Partners, the private equity arm of the Mahindra Group, highlighted Centre for Sight's leadership position and growth potential in the large, expanding eye care market, aligning with their healthcare investment focus including single specialty practices. Parag Shah, Managing Partner at Mahindra Partners, emphasized confidence in Dr. Mahipal Sachdev's team and their execution focus. The investment reflected Mahindra's values of sustainable growth and societal impact. In 2024, ChrysCapital invested up to $100 million in a mix of primary and secondary transactions, acquiring Mahindra Holdings' entire stake from the 2019 deal and taking a significant minority position to fuel further expansion into Tier I and II cities, building on the network of 83 centers across 39 cities at that time. This exit underscored the company's robust growth and profitability over the prior five years, including resilience during COVID.
Jul 2013Series AZ47$5M-Centre for Sight, an Indian eye care chain founded in 1996 and incorporated in 2002 by Dr. Mahipal Sachdev, received a Series B investment from Z47 (formerly Matrix Partners India) on July 3, 2013. The company provides comprehensive eye-care services across multiple centers in India. Z47 later fully exited its stake in 2019 during Mahindra Partners' investment of INR 206.5 Cr in a mix of primary and secondary.

Who has invested in Centre for Sight?

4 investors have backed Centre for Sight across its funding rounds, including Z47, ChrysCapital, Mahindra Partners and Mahipal Sachdev.

Lead investors include Mahindra Partners.


Centre for Sight Investors

Investors in Centre for Sight by funding rounds participated
InvestorHQRoundsRoleFirst check
Mahipal SachdevIndiaNew Delhi1ParticipantMay 2019
Z47IndiaMumbai1ParticipantJul 2013

This data is available for Pro users. Sign up to see all 4 Centre for Sight investors.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

Acquisitions by Centre for Sight

Centre for Sight has acquired 1 company to date.

Last acquisition by Centre for Sight was on September 4th 2024. Centre for Sight acquired Laxmi Eye Hospital and Institute for undisclosed valuation.


Latest Acquisitions by Centre for Sight

Laxmi Eye Hospital and Institute
Description
Laxmi Eye Hospital and Institute is a Kathmandu-based ophthalmology center offering cataract surgeries, glaucoma treatments, squint corrections, and retina services. Established in 2010, it performs 10,000-plus procedures annually, equipped with phacoemulsification units and OCT scanners, serving patients from Nepal and neighboring regions.
HQ CountryIndia
HQ City
Mumbai
Deal Date4 Sep 2024
Valuationundisclosed
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Centre for Sight acquisitions and their M&A valuation multiples.

Start Free Trial

Centre for Sight Competitors

Centre for Sight competitors include listed companies like Suraksha Diagnostics, Monash IVF Group and Oncoclínicas, and private ones like Apollo Health And Lifeestyle, Beep Saúde and Regency Healthcare.

Public and private companies comparable to Centre for Sight
CompanyHQStatusRevenueEBITDAValuationRevenue Multiple
Apollo Health And LifeestyleIndiaHyderabadPrivate$48M-$199M4.1x
Suraksha DiagnosticsIndiaIndiaPublicly listed$33M$10M$185M5.4x
Monash IVF GroupAustraliaAustraliaPublicly listed$187M$30M$200M1.7x
OncoclínicasBrazilBrazilPublicly listed$1B($409M)$201M0.8x
Beep SaúdeBrazilRio de JaneiroPrivate$55M-$204M3.7x
Regency HealthcareIndiaKanpurPrivate--$180M-

Centre for Sight Public Comps

Centre for Sight is still privately-owned, but its public comps include Suraksha Diagnostics, Monash IVF Group, Oncoclínicas, Tınaztepe Sağlık, Pihlajalinna, Limes Schlosskliniken, Goodwill Pharma, Atrys Health, Centrum Medyczne ENEL-MED and Shalby.

Last FYEV/RevenueEV/EBITDA
RevenueEBITDALast FYLTM2027ELast FYLTM2027E
Suraksha Diagnostics$33M$10M5.9x5.4x19.2x17.0x
Monash IVF Group$187M$30M1.8x1.7x11.1x8.6x
Oncoclínicas$1B($409M)0.9x0.8x(2.2x)6.9x
Tınaztepe Sağlık$68M$21M2.4x-7.7x-
Pihlajalinna$732M$122M0.5x0.6x3.3x4.0x
Limes Schlosskliniken$56M$14M3.1x2.5x12.0x10.2x
Goodwill Pharma$70M$18M2.7x-10.1x-
Atrys Health$158M($12M)2.2x2.0x(29.1x)12.7x

This data is available for Pro users. Sign up to see all Centre for Sight competitors and their valuation data.

Start Free Trial

Common questions about Centre for Sight

When was Centre for Sight founded?Centre for Sight was founded in 1996.
Where is Centre for Sight headquartered?Centre for Sight is headquartered in India.
Is Centre for Sight publicly listed?No, Centre for Sight is a private, VC-backed company.
What is Centre for Sight's valuation?Centre for Sight was last valued at $192M in its undisclosed-stage round in May 2024.
How much funding has Centre for Sight raised?Centre for Sight has raised $137M across 3 funding rounds.
What was Centre for Sight's last funding round?Centre for Sight's last funding round was a $100M undisclosed-stage round in May 2024.
Who are Centre for Sight's investors?Centre for Sight's investors include Mahipal Sachdev, Z47, Mahindra Partners and ChrysCapital.
What is Centre for Sight's revenue?Centre for Sight's latest recorded revenue is $62M (May 2024).
What is Centre for Sight's revenue multiple?Centre for Sight's latest valuation implies a 3.1x revenue multiple ($192M valuation on $62M of revenue).
Which companies are comparable to Centre for Sight?Companies comparable to Centre for Sight include Apollo Health And Lifeestyle, Suraksha Diagnostics, Monash IVF Group, Oncoclínicas, Beep Saúde and Regency Healthcare.
How many companies has Centre for Sight acquired?Centre for Sight has acquired 1 company, including Laxmi Eye Hospital and Institute.

See companies similar to Centre for Sight

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial